Nancy Ryerson

Nancy Ryerson is a digital communicator with years of experience covering healthcare. Today, she's a Digital Marketing Manager at Antidote, where she manages the company's content marketing and SEO strategies. Prior to joining Antidote, Nancy spent three years at The Michael J. Fox Foundation, where she created content for Parkinson's disease patients and expanded the Foundation's email list by 100,000+ members in two years through search and social strategies. She holds a BA in English and journalism from NYU.

Find me on:

ePRO in Clinical Trials: To BYOD or Not to BYOD?

Electronic patient-reported outcomes (ePRO) in clinical trials are an effective way to gather data and include the patient voice in your trial while reducing the burden of entering data from paper forms. In a clinical trial that uses ePRO, a vendor can either provide an electronic device for the study, a site can buy devices and download an ePRO app, or patients can use their own devices.

Continue reading

Mental Illness Awareness Week: Mental Health Treatments in Development

It’s Mental Illness Awareness Week, a week dedicated to raising awareness of mental illness, which affects approximately 1 in 5 Americans in a given year.

Continue reading

What is Mild Cognitive Impairment (MCI)?

What is Mild Cognitive Impairment? Mild cognitive impairment (MCI) causes slight but noticeable memory changes and thinking problems. These thinking problems are worse than those associated with normal aging, but not as severe as Alzheimer’s disease memory loss symptoms.

Continue reading

Alzheimer’s Research Round-Up: June 2017

More than 5 million people live with Alzheimer’s today. By 2050, that number could rise to as high as 16 million. Currently, there is not an effective treatment for Alzheimer’s symptoms or anything that slows or stops the disease. Researchers are also investigating what steps we can take to prevent the disease in the first place.

Continue reading

Get our latest posts in your inbox